165 related articles for article (PubMed ID: 12582414)
21. [Studies of methyl aminolevulinate photodynamic therapy for actinic keratosis].
Fernández-Guarino M; Harto A; Jaén P
Actas Dermosifiliogr; 2010 May; 101(4):315-22. PubMed ID: 20487686
[TBL] [Abstract][Full Text] [Related]
22. Significant improvement of facial actinic keratoses after blue light photodynamic therapy with oral vitamin D pretreatment.
Gilaberte Y; Moreno R; Juarranz A; González S
J Am Acad Dermatol; 2022 Nov; 87(5):e165. PubMed ID: 35724893
[No Abstract] [Full Text] [Related]
23. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy.
Stefanidou M; Tosca A; Themelis G; Vazgiouraki E; Balas C
Eur J Dermatol; 2000; 10(5):351-6. PubMed ID: 10882942
[TBL] [Abstract][Full Text] [Related]
24. Comparative study of trichloroacetic acid vs. photodynamic therapy with topical 5-aminolevulinic acid for actinic keratosis of the scalp.
Di Nuzzo S; Cortelazzi C; Boccaletti V; Zucchi A; Conti ML; Montanari P; Feliciani C; Fabrizi G; Pagliarello C
Photodermatol Photoimmunol Photomed; 2015 Sep; 31(5):233-8. PubMed ID: 25660106
[TBL] [Abstract][Full Text] [Related]
25. The evolving role of aminolevulinic acid hydrochloride with photodynamic therapy in photoaging.
Gold MH
Cutis; 2002 Jun; 69(6 Suppl):8-13. PubMed ID: 12095068
[TBL] [Abstract][Full Text] [Related]
26. Aminolevulinic acid-photodynamic therapy for photorejuvenation.
Nootheti PK; Goldman MP
Dermatol Clin; 2007 Jan; 25(1):35-45. PubMed ID: 17126740
[TBL] [Abstract][Full Text] [Related]
27. Methyl aminolevulinate: actinic keratoses and Bowen's disease.
Morton CA
Dermatol Clin; 2007 Jan; 25(1):81-7. PubMed ID: 17126745
[TBL] [Abstract][Full Text] [Related]
28. Effective photodynamic therapy of actinic keratoses and Bowen's disease using microneedle perforation.
Kolde G; Rowe E; Meffert H
Br J Dermatol; 2013 Feb; 168(2):450-2. PubMed ID: 22804095
[No Abstract] [Full Text] [Related]
29. Keratosis lichenoides chronica: response to photodynamic therapy.
Lopez-Navarro N; Alcaraz I; Bosch RJ; Tejera A; Herrera E
J Dermatolog Treat; 2008; 19(2):124-5. PubMed ID: 18484431
[TBL] [Abstract][Full Text] [Related]
30. Aminolevulinic acid (Levulan) in photodynamic therapy of actinic keratoses.
Lang K; Schulte KW; Ruzicka T; Fritsch C
Skin Therapy Lett; 2001 Sep; 6(10):1-2, 5. PubMed ID: 11685275
[TBL] [Abstract][Full Text] [Related]
31. A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients.
Dragieva G; Prinz BM; Hafner J; Dummer R; Burg G; Binswanger U; Kempf W
Br J Dermatol; 2004 Jul; 151(1):196-200. PubMed ID: 15270891
[TBL] [Abstract][Full Text] [Related]
32. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study.
Szeimies RM; Karrer S; Radakovic-Fijan S; Tanew A; Calzavara-Pinton PG; Zane C; Sidoroff A; Hempel M; Ulrich J; Proebstle T; Meffert H; Mulder M; Salomon D; Dittmar HC; Bauer JW; Kernland K; Braathen L
J Am Acad Dermatol; 2002 Aug; 47(2):258-62. PubMed ID: 12140473
[TBL] [Abstract][Full Text] [Related]
33. Methyl aminolaevulinate-photodynamic therapy for actinic keratoses, squamous cell carcinoma in situ and superficial basal cell carcinoma employing a square wave intense pulsed light device for photoactivation.
Downs AM; Bower CB; Oliver DA; Stone CA
Br J Dermatol; 2009 Jul; 161(1):189-90. PubMed ID: 19416229
[No Abstract] [Full Text] [Related]
34. Cyclic photodynamic therapy delays first onset of actinic keratoses in renal transplant recipients: a 5-year randomized controlled trial with 12-month follow-up.
Togsverd-Bo K; Sandberg C; Helsing P; Mørk G; Wennberg AM; Wulf HC; Haedersdal M
J Eur Acad Dermatol Venereol; 2022 Nov; 36(11):e946-e948. PubMed ID: 35753046
[No Abstract] [Full Text] [Related]
35. Long-term efficacy and safety of daylight photodynamic therapy with methyl amninolevulinate for actinic keratosis of the face and scalp.
Fargnoli MC; Piccioni A; Neri L; Tambone S; Pellegrini C; Peris K
Eur J Dermatol; 2017 Feb; 27(1):89-91. PubMed ID: 27748261
[No Abstract] [Full Text] [Related]
36. Topical delta-aminolevulinic acid-based photodynamic therapy for Japanese actinic keratoses.
Itoh Y; Ninomiya Y; Henta T; Tajima S; Ishibashi A
J Dermatol; 2000 Aug; 27(8):513-8. PubMed ID: 10989575
[TBL] [Abstract][Full Text] [Related]
37. Photodynamic therapy for actinic keratosis followed by 5-fluorouracil reaction.
Marcus L
Dermatol Surg; 2003 Oct; 29(10):1061-4; discussion 1064-5. PubMed ID: 12974706
[TBL] [Abstract][Full Text] [Related]
38. Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer.
Lehmann P
Br J Dermatol; 2007 May; 156(5):793-801. PubMed ID: 17419691
[TBL] [Abstract][Full Text] [Related]
39. Photodynamic therapy simplified: nonprepared, moderate-grade actinic keratosis lesions respond equally well to 5-aminolaevulinic acid patch photodynamic therapy as do mild lesions.
Szeimies RM; Hauschild A; Ortland C; Moor AC; Stocker M; Surber C
Br J Dermatol; 2015 Nov; 173(5):1277-9. PubMed ID: 25940103
[No Abstract] [Full Text] [Related]
40. Methyl aminolevulinate photodynamic therapy for actinic keratosis does not affect peripheral regulatory T-cell level or function.
Reginato E; Gruber-Wackernagel A; Wolf P
Photodermatol Photoimmunol Photomed; 2015 Sep; 31(5):274-8. PubMed ID: 25847118
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
